HealthEquity (NASDAQ:HQY) Research Coverage Started at BTIG Research

BTIG Research initiated coverage on shares of HealthEquity (NASDAQ:HQY) in a report published on Wednesday, Analyst Ratings Network reports. The brokerage issued a neutral rating on the stock.

Several other equities analysts have also recently commented on HQY. Guggenheim cut shares of HealthEquity from a buy rating to a neutral rating in a research report on Monday, November 23rd. Wells Fargo & Company raised their price target on shares of HealthEquity from $63.00 to $70.00 and gave the stock an overweight rating in a research note on Wednesday, September 9th. Cantor Fitzgerald raised their price target on shares of HealthEquity from $70.00 to $77.00 and gave the stock an overweight rating in a research note on Tuesday, December 8th. BidaskClub upgraded shares of HealthEquity from a hold rating to a buy rating in a research note on Thursday, December 31st. Finally, Barrington Research raised their price target on shares of HealthEquity from $70.00 to $75.00 and gave the stock an outperform rating in a research note on Tuesday, December 8th. One research analyst has rated the stock with a sell rating, five have given a hold rating and ten have issued a buy rating to the company. The stock currently has a consensus rating of Buy and an average price target of $69.00.

Shares of NASDAQ HQY opened at $75.27 on Wednesday. HealthEquity has a fifty-two week low of $34.40 and a fifty-two week high of $88.78. The stock has a market cap of $5.80 billion, a price-to-earnings ratio of 1,505.70, a PEG ratio of 4.64 and a beta of 1.63. The company has a debt-to-equity ratio of 0.69, a quick ratio of 2.49 and a current ratio of 2.62. The firm’s 50-day simple moving average is $69.20 and its 200 day simple moving average is $59.07.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Sunday, December 6th. The company reported $0.41 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.36 by $0.05. HealthEquity had a net margin of 0.44% and a return on equity of 7.65%. The firm had revenue of $179.40 million for the quarter, compared to analysts’ expectations of $176.79 million. During the same quarter last year, the firm earned $0.47 EPS. The company’s quarterly revenue was up 14.2% compared to the same quarter last year. On average, sell-side analysts predict that HealthEquity will post 1.15 EPS for the current year.

In other news, EVP Larry L. Trittschuh sold 6,420 shares of the business’s stock in a transaction on Tuesday, December 22nd. The shares were sold at an average price of $70.00, for a total transaction of $449,400.00. Following the completion of the transaction, the executive vice president now directly owns 23,129 shares in the company, valued at approximately $1,619,030. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP William Robert Otten sold 1,925 shares of the business’s stock in a transaction on Thursday, December 10th. The shares were sold at an average price of $65.00, for a total transaction of $125,125.00. Following the transaction, the vice president now owns 36,234 shares of the company’s stock, valued at $2,355,210. The disclosure for this sale can be found here. Insiders sold a total of 20,356 shares of company stock valued at $1,420,681 over the last quarter. 3.70% of the stock is owned by company insiders.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. grew its position in shares of HealthEquity by 2.2% during the 3rd quarter. BlackRock Inc. now owns 8,671,586 shares of the company’s stock valued at $445,459,000 after purchasing an additional 189,130 shares in the last quarter. Wasatch Advisors Inc. lifted its holdings in shares of HealthEquity by 24.5% during the 3rd quarter. Wasatch Advisors Inc. now owns 3,971,124 shares of the company’s stock worth $203,996,000 after acquiring an additional 780,916 shares during the last quarter. William Blair Investment Management LLC lifted its holdings in shares of HealthEquity by 43.6% during the 3rd quarter. William Blair Investment Management LLC now owns 3,650,089 shares of the company’s stock worth $187,505,000 after acquiring an additional 1,108,938 shares during the last quarter. Jackson Square Partners LLC lifted its holdings in shares of HealthEquity by 60.8% during the 3rd quarter. Jackson Square Partners LLC now owns 3,299,782 shares of the company’s stock worth $169,509,000 after acquiring an additional 1,247,824 shares during the last quarter. Finally, ArrowMark Colorado Holdings LLC lifted its holdings in shares of HealthEquity by 94.6% during the 3rd quarter. ArrowMark Colorado Holdings LLC now owns 2,460,733 shares of the company’s stock worth $126,408,000 after acquiring an additional 1,196,238 shares during the last quarter. Hedge funds and other institutional investors own 85.22% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc providing technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Further Reading: Convertible Shares

Analyst Recommendations for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.